# Aromatase Inhibitors in the Treatment of Male Infertility

> **NCT00440180** · PHASE3 · TERMINATED · sponsor: **University of Utah** · enrollment: 20 (actual)

## Conditions studied

- Obesity
- Oligospermia

## Interventions

- **DRUG:** Anastrozole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00440180
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Not able meet target enrollment.
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440180, "Aromatase Inhibitors in the Treatment of Male Infertility". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00440180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
